JAZZ

Jazz Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth↓ 0/10
  • Momentum↑ 7/10
Jazz Pharmaceuticals sales and earnings growth
JAZZ Growth
Low
  • Revenue Y/Y↓ 4.14%
  • EPS Y/Y↓ -180.40%
  • FCF Y/Y↑ 18.30%
Jazz Pharmaceuticals gross and profit margin trends
JAZZ Profitability
Neutral
  • Gross margin ↑ 88.50%
  • EPS margin↓ -8.90%
  • ROIC↓ -7.00%
Jazz Pharmaceuticals net debt vs free cash flow
JAZZ Risk
Good
  • Debt / Equity↓ 1.4
  • Debt / FCF↓ 3.1
  • Interest coverage↓ -2.5

Jazz Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Biotechnology stocks ↗